… In 2004, cetuximab was approved by US Food and Drug Administration (FDA) as a treatment
for patients with colorectal cancer who had positive EGFR expression as detected by the …

Objectives To investigate the incidence of brain injuri in premature infants in ten hospitals of
seven large cities in China sponsored by the Subspecialty Group of Neonatology of …

… Do you want to receive a summary report of this study after it has been completed? … than
Western medicine. 2. Overall, I believe in Western medicine better than Chinese medicine 3. …

… or in conjunction with pulmonary hypertension. Fibrosis can … led to approval by the Food
and Drug Administration (80). The … approved for treating idiopathic pulmonary fibrosis) versus …

… of nanobody drugs used for intravenous, subcutaneous, oral and inhalation drug delivery
routes was reviewed, the feasibility, safety and therapeutic effect of different drug delivery …

… The applications of ultrafine crystals in inhalation, energetic materials and poorly water insoluble
drugs were summarized. … Finally, we outlook the future development of ultrafine crystals. …

… The addition of SMY can rapidly improve the pulmonary function of patients with chronic
obstructive pulmoriary disease (COPD) combined with pulmonary interstitial fibrosis and inhibit …

… evaluate a bioresorbable drug delivery system capable of local extended delivery of FK506
… After 72 hours the media was aspirated from the wells, the DRG’s were fixed with methanol …

… in the pulmonary tissue … of drug administration and serum sample collecting for use with
normal spleen cells. Serum samples were collected at 0.5, 1, 2, 4, 6, 8, 12 and 24 h after the last …

… , its chemotaxis could release inflammatory factors to mediate the pulmonary inflammatory
storm response. Injections with LPS twice could further induce pulmonary inflammation and …